DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
DOVA
Delisted
DOVA was delisted on the 11th of November, 2019.
58 hedge funds and large institutions have $64.4M invested in Dova Pharmaceuticals, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
58
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
1 | +$2.67M | |
2 | +$493K | |
3 | +$463K | |
4 |
Citadel Advisors
Miami,
Florida
|
+$301K |
5 |
Squarepoint
New York
|
+$137K |
Top Sellers
1 | -$21.5M | |
2 | -$3.81M | |
3 | -$2.44M | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.29M |
5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.29M |